James Maynard

795 total citations
12 papers, 177 citations indexed

About

James Maynard is a scholar working on Cognitive Neuroscience, Experimental and Cognitive Psychology and Physiology. According to data from OpenAlex, James Maynard has authored 12 papers receiving a total of 177 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cognitive Neuroscience, 4 papers in Experimental and Cognitive Psychology and 4 papers in Physiology. Recurrent topics in James Maynard's work include Sleep and Wakefulness Research (6 papers), Sleep and related disorders (4 papers) and Obstructive Sleep Apnea Research (4 papers). James Maynard is often cited by papers focused on Sleep and Wakefulness Research (6 papers), Sleep and related disorders (4 papers) and Obstructive Sleep Apnea Research (4 papers). James Maynard collaborates with scholars based in United States, United Kingdom and Canada. James Maynard's co-authors include Paula K. Schweitzer, Stephen Thein, Christopher L. Drake, Hélène A. Emsellem, Scott A. Sands, Luigi Taranto‐Montemurro, Russell Rosenberg, R. Bart Sangal, Joseph Ojile and Bruce Corser and has published in prestigious journals such as Neurology, American Journal of Respiratory and Critical Care Medicine and Medicine & Science in Sports & Exercise.

In The Last Decade

James Maynard

12 papers receiving 174 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James Maynard United States	8	91	75	64	33	28	12	177
Maryann C. Deak United States	7	62 0.7×	103 1.4×	42 0.7×	78 2.4×	17 0.6×	12	198
Pierpaolo Baiamonte Italy	6	221 2.4×	37 0.5×	135 2.1×	44 1.3×	5 0.2×	7	266
Steven Holfinger United States	6	87 1.0×	43 0.6×	45 0.7×	41 1.2×	26 0.9×	16	152
Antoine Guillot France	4	78 0.9×	149 2.0×	38 0.6×	108 3.3×	26 0.9×	4	220
Nattapong Jaimchariyatam Thailand	12	167 1.8×	85 1.1×	126 2.0×	72 2.2×	13 0.5×	21	285
Erica Lombardi Italy	6	34 0.4×	45 0.6×	16 0.3×	7 0.2×	7 0.3×	10	192
Mason Harris Canada	5	73 0.8×	143 1.9×	35 0.5×	103 3.1×	26 0.9×	7	231
Shintaro Chiba Japan	11	188 2.1×	78 1.0×	118 1.8×	65 2.0×	16 0.6×	33	351
Elisa Morrone Italy	6	73 0.8×	104 1.4×	48 0.8×	63 1.9×	7 0.3×	12	182
Xiaosong Dong China	8	164 1.8×	132 1.8×	132 2.1×	114 3.5×	26 0.9×	36	280

Countries citing papers authored by James Maynard

Since Specialization

Citations

This map shows the geographic impact of James Maynard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Maynard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Maynard more than expected).

Fields of papers citing papers by James Maynard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Maynard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Maynard. The network helps show where James Maynard may publish in the future.

Co-authorship network of co-authors of James Maynard

This figure shows the co-authorship network connecting the top 25 collaborators of James Maynard. A scholar is included among the top collaborators of James Maynard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Maynard. James Maynard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Schweitzer, Paula K., Luigi Taranto‐Montemurro, Joseph Ojile, et al.. (2023). The Combination of Aroxybutynin and Atomoxetine in the Treatment of Obstructive Sleep Apnea (MARIPOSA): A Randomized Controlled Trial. American Journal of Respiratory and Critical Care Medicine. 208(12). 1316–1327. 41 indexed citations

Ojile, Joseph, Paula K. Schweitzer, Stephen Thein, et al.. (2023). 0538 Mariposa: Oral Therapy AD109 Improves Objective & Patient Reported Outcomes In OSA. Randomized, Placebo Controlled Clinical Trial. SLEEP. 46(Supplement_1). A237–A237. 2 indexed citations

Bogan, Richard, James Maynard, Rachel Neuwirth, et al.. (2023). Safety and pharmacodynamics of a single infusion of danavorexton in adults with obstructive sleep apnea experiencing excessive daytime sleepiness despite adequate use of CPAP. Sleep Medicine. 107. 229–235. 11 indexed citations

Schweitzer, Paula K., et al.. (2022). Efficacy of atomoxetine plus oxybutynin in the treatment of obstructive sleep apnea with moderate pharyngeal collapsibility. Sleep And Breathing. 27(2). 495–503. 23 indexed citations

Maynard, James, et al.. (2021). Increase in Volitional Muscle Activation from Childhood to Adulthood: A Systematic Review and Meta-analysis. Medicine & Science in Sports & Exercise. 54(5). 789–799. 12 indexed citations

Rubens, Robert, Tina M. Olsson, Rachel Neuwirth, et al.. (2021). Safety and efficacy of TAK-925 in adults with obstructive sleep apnea who experience excessive daytime sleepiness despite adequate use of CPAP (4278). Neurology. 96(15_supplement). 2 indexed citations

Weaver, Terri E., Christopher L. Drake, Heike Beneš, et al.. (2020). Effects of Solriamfetol on Quality-of-Life Measures from a 12-Week Phase 3 Randomized Controlled Trial. Annals of the American Thoracic Society. 17(8). 998–1007. 31 indexed citations

Sen-Gupta, Ellora, Donald E. Wright, John A. Wright, et al.. (2019). A Pivotal Study to Validate the Performance of a Novel Wearable Sensor and System for Biometric Monitoring in Clinical and Remote Environments. PubMed. 3(1). 1–13. 25 indexed citations

Dotan, Raffy, et al.. (2019). Isometric-based test improves EMG-threshold determination in boys vs. men. European Journal of Applied Physiology. 119(9). 1971–1979. 12 indexed citations

10.

Spiegelstein, Ofer, Jasper Stevens, Joop van Gerven, et al.. (2016). Pharmacokinetics, pharmacodynamics and safety of CEP-26401, a high-affinity histamine-3 receptor antagonist, following single and multiple dosing in healthy subjects. Journal of Psychopharmacology. 30(10). 983–993. 7 indexed citations

11.

Broder, Gail, James Maynard, Shelly Karuna, et al.. (2014). Implementing Good Participatory Practice (GPP) in HVTN505 - The HIV Vaccine Trials Network (HVTN) Experience. AIDS Research and Human Retroviruses. 30(S1). A105–A106. 1 indexed citations

12.

Simen, Arthur A., Junshui Ma, Vladimir Svetnik, et al.. (2014). Efavirenz modulation of sleep spindles and sleep spectral profile. Journal of Sleep Research. 24(1). 66–73. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact